| Literature DB >> 33313450 |
Zhou Jian1,2,3, Tian Zhuang1,2,3, Tian Qinyu1,2,4, Peng Liqing1,2, Li Kun1,2, Luo Xujiang1,2, Wang Diaodiao3, Yang Zhen1,2, Jiang Shuangpeng1,2, Sui Xiang1,2, Huang Jingxiang1,2, Liu Shuyun1,2, Hao Libo1,2, Tang Peifu1,2, Yao Qi3, Guo Quanyi1,2.
Abstract
Appropriate biomimetic scaffolds created via 3D bioprinting are promising methods for treating damaged menisci. However, given the unique anatomical structure and complex stress environment of the meniscus, many studies have adopted various techniques to take full advantage of different materials, such as the printing combined with infusion, or electrospining, to chase the biomimetic meniscus, which makes the process complicated to some extent. Some researchers have tried to tackle the challenges only by 3D biopringting, while its alternative materials and models have been constrained. In this study, based on a multilayer biomimetic strategy, we optimized the preparation of meniscus-derived bioink, gelatin methacrylate (GelMA)/meniscal extracellular matrix (MECM), to take printability and cytocompatibility into account together. Subsequently, a customized 3D bioprinting system featuring a dual nozzle + multitemperature printing was used to integrate the advantages of polycaprolactone (PCL) and meniscal fibrocartilage chondrocytes (MFCs)-laden GelMA/MECM bioink to complete the biomimetic meniscal scaffold, which had the best biomimetic features in terms of morphology and components. Furthermore, cell viability, mechanics, biodegradation and tissue formation in vivo were performed to ensure that the scaffold had sufficient feasibility and functionality, thereby providing a reliable basis for its application in tissue engineering.Entities:
Keywords: 3D bioprinting; Meniscus; Scaffold; Tissue engineering
Year: 2020 PMID: 33313450 PMCID: PMC7711190 DOI: 10.1016/j.bioactmat.2020.11.027
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Parameters for printing the biomimetic meniscal scaffold.
| Project | Parameter |
|---|---|
| Model | Biomaker |
| Design software | Biomaker |
| Printing system | Dual-nozzle + Multitemperature printing system |
| Power drive | Stepping motor |
| Type | |
| Nozzle 1 (PCL) | High-precision dispensing nozzle (400 μm in inner diameter) |
| Nozzle 2 (hydrogel) | TT nozzle (500 μm in inner diameter) |
| Moving speed | |
| Nozzle 1 | 5 mm/s |
| Nozzle 2 | 5 mm/s |
| Temperature | |
| Nozzle 1 | 85 °C |
| Nozzle 2 | 20 °C |
| Filling | Cross mesh |
| Curing | Blue light crosslinking (405 nm) |
| Strand spacing (center to center) | 1.5 mm |
| Printing platform temperature | 20 °C |
Fig. 1Process of printing the biomimetic meniscal scaffold. The bioink was prepared by mixing ultrasonicated MECM, GelMA and MFCs at specific concentrations. Meanwhile, the sheep meniscus was scanned by CT, modeled in Mimics, and used to plan the printing path. The prepared bioink and PCL were printed under the designed printing parameters according to the established printing path, and finally, printing of the biomimetic meniscal scaffold was completed.
Fig. 2Characterization of printable MECM. (a) Effect of ultrasonication time on the particle size of MECM. (b) Effect of treatment method on the particle size of MECM. (c) Quantitative distribution of the particle size. (d) Gross observation. (e) SEM images (scale bar: 1 μm). (f) Type I collagen immunofluorescence images (scale bar: 500 mm). (g) Quantitative analysis of the collagen concentration (**P < 0.01, ***P < 0.001).
Fig. 3Cytocompatibility of the meniscus-derived bioink. (a) CCK-8 assays results of MFCs cocultured with different hydrogels for 1–7 days. (b) Comparative gene expression analysis for chondrogenic SOX9, COL1A2 and COL2A1 in GelMA and GelMA/MECM at 14days. (c) Immunofluorescence images showing the chondrogenic phenotype of MFCs in GelMA and GelMA/MECM constructs by COL type I staining (Green), cell nuclei (DAPI, blue) and F-actin (Rhodamine-phalloidin, red) (scale bar: 500 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 4Rheological characteristics and printability of the bioinks. (a–d) Rheological characteristics of the bioink: (a) Loss modulus (G″) and storage modulus (G′) at different angular frequencies. (b) Variation in viscosity with varying shear rate at the gelation temperature. (c) Gelation kinetics from 15 °C to 37 °C. (d) Variations in loss modulus (G″) and storage modulus (G′) from 37 °C (T0) to a fixed temperature (T1, referring to legends). The above experiments were repeated in triplicate. GelMA/MECM's transition of state from sol at 37 °C (e) to gel at 20 °C (f). (g) Printability of GelMA/MECM (scale bar: 1 cm). (h) GelMA/MECM hydrogel under a light microscope (scale bar: 1 mm). GelMA's transition of state from sol at 37 °C (i) to gel at 15 °C (j). (k) Printability of GelMA (scale bar: 1 cm). (l) GelMA hydrogel under a light microscope (scale bar: 1 mm). (m) Spreading ratio of the bioinks (ns: P > 0.05).
Fig. 5Development of the biomimetic meniscal scaffold system. The primary model(a-d): the gross observations (a) (scale bar:1 cm), the microscopic images (b) (scale bar: 1 cm) and SEM images (c, d) (scale bar: 500 μm) of the hydrogel scaffold (“GelMA/MECM” hydrogel, abbreviated as “hydrogel” in subsequent experiments), PCL scaffold and simple square scaffold from left to right. (e) Process of printing the biomimetic meniscal scaffold. (f) Specific details of the meniscal model. (g) Actual diameter of the strands of the meniscal scaffold.
Fig. 6Cell viability after printing with a single nozzle (hydrogel+MFCs) and dual nozzles (PCL+hydrogel+MFCs). (a) Confocal images of two constructs after live-dead staining at two time points (scale bar: 500 μm). The panoramic scanning (4×4) of the constructs printed by a single nozzle (b, black part was hole) and dualnozzles (c, black part was PCL) at 1 day (scale bar: 1 mm). (d) Quantitative results for cell viability (*P < 0.05, ns: P > 0.05).
Fig. 7Mechanical properties of the scaffolds printed by single nozzle and dual-nozzle. (a) Compressive stress-strain curve. (b) Compressive Young's modulus (**P < 0.01). (c) Tensile stress-strain curve. (d) Tensile Young's modulus (**P < 0.01).
Fig. 8Quantitative fluorescence analysis of subcutaneous hydrogel degradation. (a) Variation in the fluorescence intensity of all specimens. The specimens in green circle cultured in PBS as control group. (b) Quantitative fluorescence analysis of three subcutaneous specimens from each group. (c) The process of surgical operation. (d) Dissection of the samples' position after the fluorescence disappearance. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
The status of implants and regenerative tissue. Each parameter was scored from 1 to 3.
| PCL+hydrogel | PCL | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 months | 6 months | 3 months | 6 months | |||||||||||||
| S1 | S2 | S3 | Mean | S4 | S5 | S6 | Mean | S7 | S8 | S9 | Mean | S10 | S11 | S14 | Mean | |
| Implant position | 3 | 3 | 3 | 3.0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 1 | 3 | 1.7 |
| Integration | 3 | 2 | 2 | 2.3 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Tissue | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1.7 | 3 | 1 | 1 | 1.7 |
Fig. 9Analysis of the biodegradation of scaffolds in situ. (a) Gross view of the implant and femoral condyles (scale bar: 1 cm),with the implants location shown in red circles. (b) Variation in the molecular weight of PCL. (c) Variation in the elastic modulus of PCL (****P < 0.0001). (d) Variation in the hardness of PCL (***P < 0.001). (e) Histological evaluation by collagen type I immunohistochemistry and picrosirius red (PR) and toluidine blue (TB) staining (scale bar: 500 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 10Preliminary evaluation of the regenerative effect of scaffolds in a nude mouse model (scale bar: 500 μm).